Tag: GCP compliance

Exploratory vs Confirmatory Sensitivity Analyses: Where to Draw the Line

Posted on By digi

Exploratory vs Confirmatory Sensitivity Analyses: Where to Draw the Line Exploratory vs Confirmatory Sensitivity Analyses: Where to Draw the Line In the realm of applied clinical trials, sensitivity analyses serve as pivotal tools that support the robustness and credibility of trial outcomes. As clinical research professionals, particularly in the domains of clinical operations, regulatory affairs,…

Read More “Exploratory vs Confirmatory Sensitivity Analyses: Where to Draw the Line” »

Missing Data Strategies & Sensitivity Analyses

Common Documentation Gaps That Undermine Confidence in RBM Programs

Posted on By digi

Common Documentation Gaps That Undermine Confidence in RBM Programs Common Documentation Gaps That Undermine Confidence in RBM Programs The transition to Risk-Based Monitoring (RBM) has transformed the clinical trial landscape, promising enhanced efficiency and improved data quality. However, the effective implementation of RBM programs hinges critically on meticulous documentation. In this step-by-step tutorial, we will…

Read More “Common Documentation Gaps That Undermine Confidence in RBM Programs” »

Documentation for Regulators

Measuring RBM Effectiveness: KPIs That Matter to Quality and Regulators

Posted on By digi

Measuring RBM Effectiveness: KPIs That Matter to Quality and Regulators Measuring RBM Effectiveness: KPIs That Matter to Quality and Regulators In the rapidly evolving environment of clinical trials, particularly for organizations like Sarah Cannon Clinical Trials, understanding and measuring Risk-Based Monitoring (RBM) effectiveness is critical. This tutorial serves as a comprehensive guide for clinical operations,…

Read More “Measuring RBM Effectiveness: KPIs That Matter to Quality and Regulators” »

RBM Effectiveness Metrics

KPIs to Track Migration Quality, Timeliness and Business Impact

Posted on By digi

KPIs to Track Migration Quality, Timeliness and Business Impact KPIs to Track Migration Quality, Timeliness and Business Impact In the evolving landscape of clinical research, the successful execution of a phase 3b clinical trial is highly dependent on the integrity and timely migration of data. Data migration forms a critical aspect of any clinical trial,…

Read More “KPIs to Track Migration Quality, Timeliness and Business Impact” »

Data Migration & Integration

Archival and Long-Term Retention Requirements for Clinical Trial Data

Posted on By digi

Archival and Long-Term Retention Requirements for Clinical Trial Data Archival and Long-Term Retention Requirements for Clinical Trial Data Managing clinical trial data involves stringent regulatory requirements that ensure the integrity and accessibility of the data over extended periods. This article provides a comprehensive, step-by-step guide to archival and long-term retention requirements for clinical trial data,…

Read More “Archival and Long-Term Retention Requirements for Clinical Trial Data” »

Archival & Long-Term Retention

Regulatory Expectations for Missing Data Handling in Pivotal Studies

Posted on By digi

Regulatory Expectations for Missing Data Handling in Pivotal Studies Clinical trials generate vast amounts of data; however, incomplete datasets due to missing data can significantly impact the integrity and outcomes of a study. Regulatory agencies, such as the FDA, EMA, and MHRA, have established guidelines that dictate how missing data should be handled in pivotal…

Read More “Regulatory Expectations for Missing Data Handling in Pivotal Studies” »

Missing Data Strategies & Sensitivity Analyses

Harmonizing RBM Narratives Across Global Regulatory Submissions

Posted on By digi

Harmonizing RBM Narratives Across Global Regulatory Submissions Harmonizing RBM Narratives Across Global Regulatory Submissions Introduction to Risk-Based Monitoring in Clinical Trials Risk-Based Monitoring (RBM) is an essential paradigm in modern clinical trial management, enabling sponsors and clinical research organizations (CROs) to address inefficiencies inherent in traditional monitoring methods. By emphasizing the identification, assessment, and mitigation…

Read More “Harmonizing RBM Narratives Across Global Regulatory Submissions” »

Documentation for Regulators

Using Metrics and Case Examples to Strengthen RBM Justifications

Posted on By digi

Using Metrics and Case Examples to Strengthen RBM Justifications Risk-Based Monitoring (RBM) has become a crucial methodology in the realm of clinical trial management. By using advanced metrics and case examples, clinical research professionals can effectively justify the adoption of RBM strategies to regulators. This tutorial will provide detailed steps, practical examples, and a comprehensive…

Read More “Using Metrics and Case Examples to Strengthen RBM Justifications” »

Documentation for Regulators

Risk Assessments for Large-Scale Historical Data Migrations

Posted on By digi

Risk Assessments for Large-Scale Historical Data Migrations Risk Assessments for Large-Scale Historical Data Migrations In the intricate landscape of clinical trials, particularly within the realms of sarah cannon clinical trials and nida clinical trials, the management and integrity of data are paramount. This necessity grows even more acute during large-scale historical data migrations. These processes,…

Read More “Risk Assessments for Large-Scale Historical Data Migrations” »

Data Migration & Integration

Governance Models for Ongoing Integration and Data Lifecycle Management

Posted on By digi

Governance Models for Ongoing Integration and Data Lifecycle Management In the rapidly evolving landscape of clinical trials, especially with the advent of COVID clinical trials and the subsequent shift towards more integrated data management systems, the need for robust governance models has never been more paramount. This article serves as a comprehensive guide for clinical…

Read More “Governance Models for Ongoing Integration and Data Lifecycle Management” »

Data Migration & Integration